These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23280372)

  • 1. Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
    Montenegro JM; Grazu V; Sukhanova A; Agarwal S; de la Fuente JM; Nabiev I; Greiner A; Parak WJ
    Adv Drug Deliv Rev; 2013 May; 65(5):677-88. PubMed ID: 23280372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization of inorganic nanoparticles for bioimaging applications.
    Erathodiyil N; Ying JY
    Acc Chem Res; 2011 Oct; 44(10):925-35. PubMed ID: 21648430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic nanoparticles in drug delivery.
    Mattoussi H; Rotello VM
    Adv Drug Deliv Rev; 2013 May; 65(5):605-6. PubMed ID: 23608640
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles.
    Sperling RA; Parak WJ
    Philos Trans A Math Phys Eng Sci; 2010 Mar; 368(1915):1333-83. PubMed ID: 20156828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy.
    Guo YY; Huang L; Zhang ZP; Fu DH
    Curr Med Sci; 2020 Jun; 40(3):463-473. PubMed ID: 32681251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
    Zhong Y; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic nanoparticles for predictive oncology of breast cancer.
    Yezhelyev M; Yacoub R; O'Regan R
    Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles.
    Haque ST; Chowdhury EH
    Curr Drug Deliv; 2018; 15(4):485-496. PubMed ID: 29165073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.
    Hossen MN; Kajimoto K; Akita H; Hyodo M; Harashima H
    J Control Release; 2012 Oct; 163(2):101-10. PubMed ID: 22982237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo degeneration and the fate of inorganic nanoparticles.
    Feliu N; Docter D; Heine M; Del Pino P; Ashraf S; Kolosnjaj-Tabi J; Macchiarini P; Nielsen P; Alloyeau D; Gazeau F; Stauber RH; Parak WJ
    Chem Soc Rev; 2016 May; 45(9):2440-57. PubMed ID: 26862602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
    Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
    Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
    Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S
    Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.
    Roy S; Johnston AH; Newman TA; Glueckert R; Dudas J; Bitsche M; Corbacella E; Rieger G; Martini A; Schrott-Fischer A
    Int J Pharm; 2010 May; 390(2):214-24. PubMed ID: 20153412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticulate drug delivery systems for cancer chemotherapy.
    Saha RN; Vasanthakumar S; Bende G; Snehalatha M
    Mol Membr Biol; 2010 Oct; 27(7):215-31. PubMed ID: 20939772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications.
    Shen M; Shi X
    Nanoscale; 2010 Sep; 2(9):1596-610. PubMed ID: 20820690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of inorganic nanoparticles mediated by biomimetic oligomers.
    Tigger-Zaborov H; Maayan G
    Org Biomol Chem; 2015 Sep; 13(34):8978-92. PubMed ID: 26222802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.